Baxter International Inc (BAX) Actualités

Baxter Reports Third-Quarter 2024 Results

Baxter third-quarter 2024 sales totaled $3.85 billion1 Third-quarter total Baxter U.S. GAAP2 diluted earnings per share (EPS) were $0.271;...

Form 8-K - Current report

Baxter to Present at UBS Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the UBS Global Healthcare Conference on Wednesday, November 13...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2024 financial results on...

Form 8-K - Current report

Form 8-K - Current report

Baxter Provides Update on North Cove, N.C., Facility and Hurricane Helene Relief Plans for Community

Baxter’s North Cove facility affected by flooding and currently closed for production as the company assesses extent of the impact Company is...

Baxter Launches Next Generation of The Vest System for Airway Clearance

Provides patients with certain chronic lung conditions and retained secretions added comfort, user-friendly touch screen and unique garment...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Baxter Appoints Jeffrey A. Craig to Its Board

Addition of Mr. Craig complements current board expertise with deep financial, broad operational and public company board experience Baxter...